Chemical Properties:
Package: Bottle, Barrel, 25kg/Barrel, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.Manufacturer Supply with High Purity and Stable Quality (S)-(+)-1,2-Propanediol CAS 4254-15-3 (R)-(-)-1,2-Propanediol CAS 4254-14-2 Chiral Compounds, High Quality, Commercial Production| Item | Specifications |
| Appearance | Colorless Transparent Liquid |
| Specific Rotation | +16.5°～ +17.0° (neat) |
| Enantiomeric Excess | e.e≥99.0% |
| Moisture (K.F) | ≤0.30% |
| Assay / Analysis Method | ≥99.0% (GC) |
| Test Standard | Enterprise Standard |
| Usage | Chiral Compounds; Pharmaceutical Intermediates |
Description:
Specifications:
Package & Storage:
| Chemical Name | (S)-(+)-1,2-Propanediol |
| Synonyms | (S)-(+)-1,2-Dihydroxypropane; (S)-(+)-Propylene Glycol |
| CAS Number | 4254-15-3 |
| CAT Number | RF-CC221 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C3H8O2 |
| Molecular Weight | 76.09 |
| Melting Point | -59℃ |
| Density | 1.036 g/mL at 20 °C(lit.) |
| Boiling Point | 186~188℃ (765 mmHg) |
| Flash Point | 107℃ |
| Refractive Index | n20/D 1.432 (lit.) |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-(+)-1,2-Propanediol (CAS: 4254-15-3) with high quality, it belongs to pharmaceutical intermediate and can be used for the synthesis of chiral intermediates and chiral drugs. Shanghai Ruifu Chemical Co., Ltd. plays an important role in the chiral chemistry, the company is committed to the production of chiral compounds. Our products are widely praised by customers. (S)-(+)-1,2-Propanediol (CAS: 4254-15-3) acts as an organic solvent and diluent used in pharmaceutical preparations. It is also used as a chiral synthetic intermediate and substrate for enzyme studies. (S)-(+)-Propane-1,2-diol is a general reagent used in organic synthesis. (S)-(+)-Propane-1,2-diol is used in the synthesis of anti-tuberculosis agents inspired by BTZ043 for MDR resistant strains.
